GlassScriptPhysician profile
Connie M Rhee
NPI 1083835276
$95,684.22
in general payments reported to CMS, 2019-2025
6 companies · $3,885 in 2025
The $3,885 reported for 2025 was more than what 93% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $15K · 2022: $31K · 2023: $17K · 2024: $5,222 · 2025: $3,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $3,436 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,499 · Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,480.00 |
| Travel and Lodging | $3,436.31 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,499.00 |
| Food and Beverage | $688.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $51,261.87 | 2019-2024 | Lokelma |
| Fresenius USA Marketing, INC. | $23,277.31 | 2019-2025 | |
| Astrazeneca Uk Limited | $9,646.50 | 2022-2023 | |
| Vifor Pharma, INC. | $4,558.51 | 2022-2025 | Veltassa |
| Dexcom, INC. | $3,808.00 | 2023-2024 | Dexcom G7 Gss (161) |
| Scpharmaceuticals INC. | $3,132.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.